Skip to main content

ALNY Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Alnylam Pharmaceuticals Inc. News

Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape

A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.

Small-Cap Health-Care Stocks: What's on Bank of America List?

The small-cap-health-care sector has struggled the past year. But now Bank of America says things are looking up and it has stock ideas.

Alnylam Rises on $2 Billion Blackstone Investment

Alnylam Pharmaceuticals rises on a report that Blackstone Group is investing $2 billion to help develop and bring to market a high-cholesterol drug.

Lack of Euphoria: Cramer's 'Mad Money' Recap

The decided lack of enthusiasm for Lyft is really good for this market, says Jim Cramer. It shows investors are behaving rationally.

Mastercard, Carrizo Oil & Gas, Duluth Holdings: 'Mad Money' Lightning Round

Jim Cramer weighs in on Mastercard, Carrizo Oil & Gas, Duluth Holdings, Alnylam Pharmaceuticals, United States Steel.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023